Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Nosocomial Infection | Research article

Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study

Authors: Hilina Motbainor, Fetlework Bereded, Wondemagegn Mulu

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Multi-drug resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa are major causes of nosocomial infections globally. They are the current World Health Organization critical priority pathogens for resistance, Antimicrobial resistance (AMR) surveillance and discovery of new antibiotics. However, there is paucity of data on nosocomial infections (NIs) caused by such superbugs in Ethiopia. Therefore, this study determined the magnitude and profile of nosocomial MDR A. baumannii and P. aeruginosa infections among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia.

Methods

A cross-sectional study was conducted at Felegehiwot referral hospital from April 1 to July 31, 2018. A total of 238 patients with blood stream, urinary tract and surgical site NIs were enrolled conveniently. Either blood, urine and wound swab specimens were collected and processed using standard bacteriological procedures. A. baumannii and P. aeruginosa isolates were identified using standard bacteriological techniques and confirmed by automated Vitek2 Compact. Antimicrobial susceptibility testing on isolates was performed using the disk diffusion technique. The results were interpreted as per the standard zone sizes of Clinical and Laboratory Standards Institute.Chi-square test was done to determine associations among variables. P value < 0.05 was considered statistical significant.

Results

The median age of participants was 29 years. Overall,20(8.4%) of patients had nosocomial MDR A. baumannii and P. aeruginosa infections. The proportion of nosocomial MDR blood stream, urinary tract and surgical site infections were 13(8.9%), 5(8.3%) and 2 (6.3%), respectively. Patients with NI had lower mean age (24.9 years) (P = 0.035). All isolates of NIs were from patients with intravenous catheterization. The frequency of NI was 9(3.8%) for MDR A. baumannii and 11(4.6%) for MDR P.aeruginosa. A. baumannii and P. aeruginosa isolates were 100% MDR. All isolates of A. baumannii and P. aeruginosa were 100% resistant to ampicillin and piperacillin.A. baumannii isolates were 33.3 and 44.5% resistance against meropenem and ciprofloxacin, respectively while P.aeruginosa isolates revealed 36.4 and 45.5% resistance against ciprofloxacin and meropenem, respectively.

Conclusions

Health care associated infections of MDR A.baumannii and P. aeruginosa are critical problems in the study area. Therefore, urgent focused interventions required to contain the spreading of MDR NIs. Treatment of NIs for patients on health care should be guided by antimicrobial susceptibility testing.
Literature
1.
go back to reference Poza M, Gayoso C, Gómez MJ, Rumbo-Feal S, Tomás M, Aranda J, et al. Exploring bacterial diversity in hospital environments by GS-FLX titanium pyrosequencing. PLoS One. 2012;7(8):e44105.CrossRef Poza M, Gayoso C, Gómez MJ, Rumbo-Feal S, Tomás M, Aranda J, et al. Exploring bacterial diversity in hospital environments by GS-FLX titanium pyrosequencing. PLoS One. 2012;7(8):e44105.CrossRef
2.
go back to reference Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, et al. Antibiotic resistance: what is so special about multidrug-resistant gram-negative bacteria? GMS Hyg Infect Control. 2017;12:1–24. Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, et al. Antibiotic resistance: what is so special about multidrug-resistant gram-negative bacteria? GMS Hyg Infect Control. 2017;12:1–24.
4.
go back to reference Revelas A. Healthcare-associated infections: a public health problem. Niger Med J. 2013;53(2):59–64.CrossRef Revelas A. Healthcare-associated infections: a public health problem. Niger Med J. 2013;53(2):59–64.CrossRef
5.
go back to reference Mitchell BG, Shaban RZ, Macbeth D, Wood CJ, Russo PL. The burden of healthcare-associated infection in Australian hospitals: A systematic review of the literature. Infect Dis Health. 2017;22:117–28.CrossRef Mitchell BG, Shaban RZ, Macbeth D, Wood CJ, Russo PL. The burden of healthcare-associated infection in Australian hospitals: A systematic review of the literature. Infect Dis Health. 2017;22:117–28.CrossRef
6.
go back to reference World Health Organization. Report on the burden of endemic health care-associated infection worldwide. WHO. 2014. World Health Organization. Report on the burden of endemic health care-associated infection worldwide. WHO. 2014.
7.
go back to reference Percival SL, Suleman L, Vuotto C, Donelli G. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J Med Microbiol. 2015;64:323–34.CrossRef Percival SL, Suleman L, Vuotto C, Donelli G. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J Med Microbiol. 2015;64:323–34.CrossRef
8.
go back to reference Tolera M, Abate D, Dheresa, M, Marami D. Bacterial nosocomial infections and antimicrobial susceptibility pattern among patients admitted at Hiwot Fana Specialized University hospital, East Ethiop Adv Med 2018; 2018: https://doi.org/https://doi.org/10.1155/2018/2127814.CrossRef Tolera M, Abate D, Dheresa, M, Marami D. Bacterial nosocomial infections and antimicrobial susceptibility pattern among patients admitted at Hiwot Fana Specialized University hospital, East Ethiop Adv Med 2018; 2018: https://​doi.​org/​https://​doi.​org/​10.​1155/​2018/​2127814.CrossRef
10.
go back to reference European Centre for Disease Prevention and Control. Point prevalence survey of health care associated infections and antimicrobial use in European acute care hospitals - protocol version 5.3. Stockholm: ECDC; 2016. European Centre for Disease Prevention and Control. Point prevalence survey of health care associated infections and antimicrobial use in European acute care hospitals - protocol version 5.3. Stockholm: ECDC; 2016.
13.
go back to reference World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva. WHO. 2017. World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva. WHO. 2017.
14.
go back to reference World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO. 2017. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO. 2017.
16.
go back to reference Ali J, Rafiq QA, Ratcliffe E. Antimicrobial resistance mechanisms and potential synthetic treatments. Future Sci OA. 2018;4(4):FSO290.CrossRef Ali J, Rafiq QA, Ratcliffe E. Antimicrobial resistance mechanisms and potential synthetic treatments. Future Sci OA. 2018;4(4):FSO290.CrossRef
20.
go back to reference Rods GP. UK standards for microbiology investigations. Public Health England. 2014. Rods GP. UK standards for microbiology investigations. Public Health England. 2014.
21.
go back to reference Cheesbourgh M District laboratory practice in tropical countries. Part II. 2nd ed. NewYork Cambridge University Press; 2006. Cheesbourgh M District laboratory practice in tropical countries. Part II. 2nd ed. NewYork Cambridge University Press; 2006.
22.
go back to reference Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by standard single disc method. Am J Clin Path. 1966;45:493–6.CrossRef Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by standard single disc method. Am J Clin Path. 1966;45:493–6.CrossRef
23.
go back to reference Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational.Supplement.CLSIdocumentM100-S25.Wayne, PA:CLSI, 2017. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational.Supplement.CLSIdocumentM100-S25.Wayne, PA:CLSI, 2017.
24.
go back to reference Johnson AP. Surveillance of antibiotic resistance. Philos Trans R Soc Lond Ser B Biol Sci. 2015;370(1670):20140080.CrossRef Johnson AP. Surveillance of antibiotic resistance. Philos Trans R Soc Lond Ser B Biol Sci. 2015;370(1670):20140080.CrossRef
25.
go back to reference Asres GS, Legese MH, Woldearegay GM. Prevalence of multidrug resistant bacteria in postoperative wound infections at Tikur Anbessa specialized hospital, Addis Ababa. Ethiopia Arch Med. 2017;9(4):1–9. Asres GS, Legese MH, Woldearegay GM. Prevalence of multidrug resistant bacteria in postoperative wound infections at Tikur Anbessa specialized hospital, Addis Ababa. Ethiopia Arch Med. 2017;9(4):1–9.
27.
go back to reference De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health. 2013;6:179–85.CrossRef De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health. 2013;6:179–85.CrossRef
28.
go back to reference Al Jarousha AM, ElJadba AHN, AlAfifi AS, ElQouqa IA. Nosocomial multidrug resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City. Palestine Int J Infect Dis. 2009;13:623–8.CrossRef Al Jarousha AM, ElJadba AHN, AlAfifi AS, ElQouqa IA. Nosocomial multidrug resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City. Palestine Int J Infect Dis. 2009;13:623–8.CrossRef
29.
go back to reference Scherbaum M, Kösters K, Mürbeth RE, Ngoa UA, Kremsner PG, Lell B, et al. Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon. BMC Infect Dis. 2014;14:124.CrossRef Scherbaum M, Kösters K, Mürbeth RE, Ngoa UA, Kremsner PG, Lell B, et al. Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon. BMC Infect Dis. 2014;14:124.CrossRef
31.
go back to reference Murni IK, Duke T, Daley AJ, Kinney S, Soenarto Y. Antibiotic resistance and mortality in children with nosocomial blood stream infection in a teaching hospital in Indonesia. Southeast Asian J Trop Med Public Health. 2016;47(5):983–93.PubMed Murni IK, Duke T, Daley AJ, Kinney S, Soenarto Y. Antibiotic resistance and mortality in children with nosocomial blood stream infection in a teaching hospital in Indonesia. Southeast Asian J Trop Med Public Health. 2016;47(5):983–93.PubMed
32.
33.
go back to reference Shanthi M, Sekar U. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes. JAPI. 2009;57:636–40.PubMed Shanthi M, Sekar U. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes. JAPI. 2009;57:636–40.PubMed
34.
go back to reference Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2018; 7:79. https://doi.org/https://doi.org/10.1186/s13756-018-0370-9. Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2018; 7:79. https://​doi.​org/​https://​doi.​org/​10.​1186/​s13756-018-0370-9.
35.
go back to reference Li L, Dai J, Xu L, Chen Z, Li X, Liu M, et al. Antimicrobial resistance and pathogen distribution in hospitalized burn patients a multicenter study in Southeast China. Med. 2018;97(34):1–9. Li L, Dai J, Xu L, Chen Z, Li X, Liu M, et al. Antimicrobial resistance and pathogen distribution in hospitalized burn patients a multicenter study in Southeast China. Med. 2018;97(34):1–9.
36.
go back to reference Jiménez-Guerra G, Heras-Cañas V, Gutierrez-Soto M, Del Pillar A-PM, Expósito-Ruiz M, Navarro-Marí JM, et al. Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: evolution of antimicrobial resistance and therapeutic alternatives. J Med Microbiol. 2018;67:790–7.CrossRef Jiménez-Guerra G, Heras-Cañas V, Gutierrez-Soto M, Del Pillar A-PM, Expósito-Ruiz M, Navarro-Marí JM, et al. Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: evolution of antimicrobial resistance and therapeutic alternatives. J Med Microbiol. 2018;67:790–7.CrossRef
37.
go back to reference Dent LL, Marshall DR, Pratap S, Hulette RB. Research article multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis. 2010;10:196.CrossRef Dent LL, Marshall DR, Pratap S, Hulette RB. Research article multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis. 2010;10:196.CrossRef
38.
go back to reference Saïdani M, Boutiba I, Ghozzi R, Kammoun A, Redjeb SB. Bacteriologic profile of bacteremia due to multi-drug resistant bacteria at Charles-Nicolle hospital of Tunis. Med Mal Infect. 2006;36:163–6.CrossRef Saïdani M, Boutiba I, Ghozzi R, Kammoun A, Redjeb SB. Bacteriologic profile of bacteremia due to multi-drug resistant bacteria at Charles-Nicolle hospital of Tunis. Med Mal Infect. 2006;36:163–6.CrossRef
39.
go back to reference Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care Centre. Indian J Burn. 2015;23(1):56–9.CrossRef Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care Centre. Indian J Burn. 2015;23(1):56–9.CrossRef
40.
go back to reference Savaþ L, Duran N, Savaþ N, Nlen Y, Ocak S. The prevalence and resistance patterns of Pseudomonas aeruginosa in intensive care units in a university hospital. Turk J Med Sci. 2005;35:317–22. Savaþ L, Duran N, Savaþ N, Nlen Y, Ocak S. The prevalence and resistance patterns of Pseudomonas aeruginosa in intensive care units in a university hospital. Turk J Med Sci. 2005;35:317–22.
41.
go back to reference Hsueh P, Liu Y, Yang D, Yan J, Wu T, Huang W, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist. 2001;7(4):373–82.CrossRef Hsueh P, Liu Y, Yang D, Yan J, Wu T, Huang W, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist. 2001;7(4):373–82.CrossRef
42.
go back to reference Somily AM, Absar MM, Arshad MZ, Aska A, Shakoor ZA, Fatani AJ, et al. Antimicrobial susceptibility patterns of multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline. Saudi Med J. 2012;33(7):750–5.PubMed Somily AM, Absar MM, Arshad MZ, Aska A, Shakoor ZA, Fatani AJ, et al. Antimicrobial susceptibility patterns of multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline. Saudi Med J. 2012;33(7):750–5.PubMed
43.
go back to reference Nwadike UV, Ojide KC, Kalu IE. Multidrug resistant Acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian tertiary hospital icu. Afr J Infect Dis. 2014;8(1):14–8.PubMedPubMedCentral Nwadike UV, Ojide KC, Kalu IE. Multidrug resistant Acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian tertiary hospital icu. Afr J Infect Dis. 2014;8(1):14–8.PubMedPubMedCentral
44.
go back to reference Manyahi J, Matee M, Majigo M, Moyo S, Mshana SE, Lyamuya EF. Predominance of multi-drug resistant bacteria pathogens causing surgical site infections in Muhimbili national hospital. Tanzania BMC Res Notes. 2014;7:500.CrossRef Manyahi J, Matee M, Majigo M, Moyo S, Mshana SE, Lyamuya EF. Predominance of multi-drug resistant bacteria pathogens causing surgical site infections in Muhimbili national hospital. Tanzania BMC Res Notes. 2014;7:500.CrossRef
45.
go back to reference Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob. 2019;18(1):2–12.CrossRef Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob. 2019;18(1):2–12.CrossRef
Metadata
Title
Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study
Authors
Hilina Motbainor
Fetlework Bereded
Wondemagegn Mulu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-4811-8

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.